Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
Clinical trial NCT00217373 · COMPLETED
Trial details
- NCT number
- NCT00217373
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2013-01-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.